What companies are EXEL's competitors?

Exelixis, Inc. (EXEL)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does EXEL compare to its peers?

The peer comparison table on this page shows Exelixis, Inc. (EXEL) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does EXEL operate in?

Exelixis, Inc. (EXEL) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification: companies with similar revenue mix, cost structure, and customer demand drivers.

EXEL

Exelixis, Inc.

NASDAQ·Biotechnology · Healthcare

$64.53$0.78−1.19%

After hours·$64.00−0.82%

Market cap$16.22B·Market closed·Oct 23 4:00 PM EDT

Frequently Asked Questions About EXEL

What companies are EXEL's competitors?: Exelixis, Inc. (EXEL)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does EXEL compare to its peers?: The peer comparison table on this page shows Exelixis, Inc. (EXEL) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does EXEL operate in?: Exelixis, Inc. (EXEL) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification: companies with similar revenue mix, cost structure, and customer demand drivers.

EXEL

Exelixis, Inc.

NASDAQ·Biotechnology · Healthcare

$64.53$0.78−1.19%

After hours·$64.00−0.82%

Market cap$16.22B·Market closed·Oct 23 4:00 PM EDT

Peers

Sort:


AZNAZNAstraZeneca PLC	AstraZeneca PLC	$171.49	$266.0B
IPSEYIPSEYIpsen S.A.	Ipsen S.A.	$43.85	$58.0B
RVMDRVMDRevolution Medicines, Inc.	Revolution Medicines, Inc.	$186.99	$40.1B
ALPMYALPMYAstellas Pharma Inc.	Astellas Pharma Inc.	$15.95	$28.6B
GMABGMABGenmab A/S	Genmab A/S	$43.79	$26.9B
INCYINCYIncyte Corporation	Incyte Corporation	$115.71	$23.5B
HCMHCMHUTCHMED (China) Limited	HUTCHMED (China) Limited	$14.36	$2.6B
SNDXSNDXSyndax Pharmaceuticals, Inc.	Syndax Pharmaceuticals, Inc.	$13.40	$1.2B
RIGLRIGLRigel Pharmaceuticals, Inc.	Rigel Pharmaceuticals, Inc.	$48.13	$899.1M
CRISCRISCuris, Inc.	Curis, Inc.	$0.39	$753.3K

Frequently Asked Questions About EXEL

What companies are EXEL's competitors?: Exelixis, Inc. (EXEL)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does EXEL compare to its peers?: The peer comparison table on this page shows Exelixis, Inc. (EXEL) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does EXEL operate in?: Exelixis, Inc. (EXEL) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification: companies with similar revenue mix, cost structure, and customer demand drivers.